PubMed · 1999 · 34 citations · 6 references
MedicineInfectious DiseasesInternal MedicineInfectious Disease PathologyMedical MicrobiologyPulmonologyInterstitial Lung DiseasePulmonary InfectionsPulmonary PathologyRespiratory DiseaseRespiratory Infectious DiseasesRespiratory Tract InfectionsCytological ExaminationCytological FeaturesNon-specific Interstitial PneumoniaPneumocystis InfectionPneumonia DiagnosisRenal Transplant CareSputum Examination
OBJECTIVE: To compare the spectrum of pulmonary disease in human immunodeficiency virus positive patients of African and European origin, with particular reference to Pneumocystis carinii pneumonia. DESIGN: Descriptive study with retrospective record review. SETTING: Tertiary care, university teaching hospitals in Johannesburg, South Africa. SUBJECTS: Sixty seven HIV-infected patients and 36 HIV-negative renal transplant patients (who served as controls) whose sputa were negative for tuberculosis and Pneumocystis carinii, and who had fibreoptic bronchoscopic evaluation for pulmonary disease between January 1985 and August 1992. MEASUREMENTS: Histological and cytological evaluation of pulmonary diseases. RESULTS: In the HIV infected group Pneumocystis carinii pneumonia was the most frequent disease in patients of both African and European origin but occurred less commonly in Africans than in Europeans (27.3% and 58.8%, respectively; p = 0.01). There was no statistically significant difference between patients of African and European origin in the frequency of any other diagnosis. In the renal transplant group the most frequent diagnosis was non-specific interstitial pneumonitis (Africans 33.3%, Europeans 37.0%), followed by Pneumocystis carinii pneumonia (Africans 22.2%, European 14.8%). There was no difference between HIV-infected and renal transplant patients in the frequency of any diagnosis. CONCLUSION: Pneumocystis carinii pneumonia should be considered in the diagnosis of HIV-infected African patients with pulmonary disease whose sputum smears for tuberculosis are negative.
6
REDUCTION IN MORTALITY FROM BREAST CANCER AFTER MASS SCREENING WITH MAMMOGRAPHY
Làszló Tabár, Ahmed Z. Gad, Lars Holmberg et al. · The Lancet · 1985 · 1.8K citations
Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.
Ingvar Andersson, Knut Aspegren, Lars Janzon et al. · BMJ · 1988 · 926 citations · Full text
Periodic breast cancer screening in reducing mortality from breast cancer